Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Medit launches the revolutionary i900, an intraoral scanning system set to redefine the scanning experience for dental clinics worldwide


SEOUL, South Korea and LONG BEACH, Calif., April 30, 2024 /PRNewswire/ -- Medit (www.medit.com), a leading provider of dental 3D scanners and digital dentistry solutions, introduces the Medit i900 intraoral scanner, setting a new standard for speed, accuracy, and comfort.

Medit launches the revolutionary i900, an intraoral scanning system set to redefine the scanning experience for dental clinics worldwide

"The brilliance of the Medit i900 lies in its sleek, unibody design," said Michael Lee, CTO of Medit. "There is complex innovation within its simplicity. The i900 is light and easy to handle, but offers the most cutting-edge technology to date."

The Medit i900 rede?nes the scanning process with the intuitive Touch Band and Touch Pad functionality. The button-free operation offers control from any angle and allows for a comfortable experience for all hand sizes. Other advanced features of the scanner streamline work?ow and optimize patient care.

"The i900 simplifies the scanning journey," said Han Ryu, CGSO of Medit. "With intuitive 360° Touch Band and Touch Pad controls, practitioners can access our groundbreaking optical engine in just a few taps. We designed the i900 for ultimate convenience and ef?ciency."

The Medit i900 is powered by Medit Link, the company's open software platform, providing access to a suite of free dental apps that encourage productivity and enhance patient care. The system provides adaptive software updates to improve smart features, patient consultations, and lab communications.

Order the Medit i900 today and experience the future of digital dentistry: https://www.medit.com/medit-i900-intraoral-scanner/

See the Medit i900 in action at these upcoming events:

About Medit

MEDIT is a global provider of 3D intraoral scanners and an all-in-one digital dentistry platform, based on its patented state-of-the-art technology. The company also develops innovative software for digital dentistry, supporting collaborative work?ows between dental clinics, technology, and labs.

MEDIT has been headquartered in Seoul, South Korea since its inception in 2000. The company also has representatives in the Americas and Europe and boasts a global network of distributors in over 100 countries. Visit MEDIT of?cial website for detailed information about MEDIT products and software, and MEDIT of?cial YouTube and social media channels for other various content.

Photo - https://mma.prnewswire.com/media/2398335/Medit_launches_revolutionary_i900_intraoral_scanning_system_set_redefine_scanning.jpg
Logo - https://mma.prnewswire.com/media/1798058/Logo_MEDIT_Logo.jpg 


These press releases may also interest you

at 18:54
The Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") has today,...

at 18:12
The global functional food ingredients market size is estimated to grow by USD 53.14 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 7.38% during the forecast period. ...

at 17:55
City of Hope®, one of the largest cancer research and treatment organizations in the United States, has been awarded $5.4 million from the California Institute for Regenerative Medicine (CIRM) to build and fund a stem cell research laboratory on its...

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...



News published on and distributed by: